Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001186627 | SCV001353104 | likely benign | Hereditary cancer-predisposing syndrome | 2019-11-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003770083 | SCV002454068 | likely benign | Familial adenomatous polyposis 1 | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001186627 | SCV002620109 | likely benign | Hereditary cancer-predisposing syndrome | 2020-09-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004008620 | SCV004837840 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-10-30 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003770083 | SCV004931177 | benign | Familial adenomatous polyposis 1 | 2024-03-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |